K. Herrup, Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?, Nature Reviews Neuroscience, vol.21, issue.5, pp.368-78, 2007.
DOI : 10.1038/nrn2124

D. Chen, Global Transcriptional Responses of Fission Yeast to Environmental Stress, Molecular Biology of the Cell, vol.14, issue.1, pp.214-243, 2003.
DOI : 10.1091/mbc.E02-08-0499

A. Bishop, Magic bullets for protein kinases, Trends in Cell Biology, vol.11, issue.4, pp.167-72, 2001.
DOI : 10.1016/S0962-8924(01)01928-6

A. Guerra-moreno, Insights from a new tool for meiotic induction in fission yeast Comment on, Cell Cycle, vol.11, pp.1620-1624, 2012.

P. Wu, Institute of Genetics and Development of Rennes; CNRS UMR 6290

R. 1. Yoo and C. , Epigenetic therapy of cancer: past, present and future, Nature Reviews Drug Discovery, vol.316, issue.1, pp.37-50, 2006.
DOI : 10.1038/nrd1930

A. Gorman, Stress management at the ER: Regulators of ER stress-induced apoptosis, Pharmacology & Therapeutics, vol.134, issue.3, pp.306-322, 2012.
DOI : 10.1016/j.pharmthera.2012.02.003

M. Macaluso, in press; PMiD:22544282, Cell Cycle, vol.11, 2012.

J. Millau, CTCF, cohesin, and histone variants: connecting the genome, Biochemistry and Cell Biology, vol.89, issue.5, pp.505-518, 2011.
DOI : 10.1139/o11-052

R. De-necochea-campion, 9:213; PMiD:22168535, J Transl Med, vol.http, pp.1479-5876, 2011.

F. Fiorentino, CTCF and BORIS Regulate Rb2/p130 Gene Transcription: A Novel Mechanism and a New Paradigm for Understanding the Biology of Lung Cancer, Molecular Cancer Research, vol.9, issue.2, pp.225-258, 2011.
DOI : 10.1158/1541-7786.MCR-10-0493

D. Ron, Signal integration in the endoplasmic reticulum unfolded protein response, Nature Reviews Molecular Cell Biology, vol.300, issue.7, pp.519-548, 2007.
DOI : 10.1038/nrm2199

K. Wiman, Pharmacological reactivation of mutant p53: from protein structure to the cancer patient, Oncogene, vol.30, issue.30, pp.4245-52, 2010.
DOI : 10.1038/onc.2010.188

. Blagosklonny-mv, Cyclotherapy: Protection of Normal Cells and Unshielding of Cancer Cells, Cell Cycle, vol.1, issue.6, pp.375-82, 2002.
DOI : 10.4161/cc.1.6.259

D. Kranz, BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways, The Journal of Cell Biology, vol.14, issue.1, pp.197-213, 2008.
DOI : 10.1126/science.1083430

D. Carvajal, Activation of p53 by MDM2 Antagonists Can Protect Proliferating Cells from Mitotic Inhibitors, Cancer Research, vol.65, issue.5, pp.1918-1942, 2005.
DOI : 10.1158/0008-5472.CAN-04-3576

D. Kranz, Nongenotoxic p53 Activation Protects Cells against S-Phase-Specific Chemotherapy, Cancer Research, vol.66, issue.21, pp.10274-80, 2006.
DOI : 10.1158/0008-5472.CAN-06-1527

. Van-leeuwen-imm, An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells, Cell Cycle, vol.1786, issue.9, pp.1851-61, 2012.
DOI : 10.4161/cc.4.11.2187

L. Vassilev, In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2, Science, vol.303, issue.5659, pp.844-852, 2004.
DOI : 10.1126/science.1092472